Cleared Special

K100050 - R & D SYSTEMS XERET HEMATOLOGY CONTROL

K100050 is the FDA 510(k) clearance for R & D SYSTEMS XERET HEMATOLOGY CONTROL by R&D Systems, Inc.. It is a Class 2 Hematology device (product code JPK) cleared through the Special 510(k) pathway after a 21-day FDA review.

K100050 · R&D Systems, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2010
Decision
21d
Days
Class 2
Risk

K100050 is an FDA 510(k) clearance for the R & D SYSTEMS XERET HEMATOLOGY CONTROL. Classified as Mixture, Hematology Quality Control (product code JPK), Class II - Special Controls.

Submitted by R&D Systems, Inc. (Minneapolis, US). The FDA issued a Cleared decision on January 29, 2010 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.8625 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all R&D Systems, Inc. devices

Submission Details

510(k) Number K100050 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 08, 2010
Decision Date January 29, 2010
Days to Decision 21 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 113d · This submission: 21d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code JPK Mixture, Hematology Quality Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.8625
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPK Mixture, Hematology Quality Control

All 133
Devices cleared under the same product code (JPK) and FDA review panel - the closest regulatory comparables to K100050.
COULTER LIN-X LINEARITY CONTROL, MODEL A81196
K100790 · Beckman Coulter, Inc. · Dec 2010
COULTER 4C-EX 300 CELL CONTROL
K100607 · Beckman Coulter, Inc. · Nov 2010
LIQUICHEK HEMATOLOGY-16 CONTROL LV, MODEL: 295LV
K091303 · Bio-Rad Laboratories · Aug 2010
R&D SYSTEMS TETIC-I PLUS HEMOTOLOGY CONTROL
K091433 · R&D Systems, Inc. · Oct 2009
COULTER BODY FLUID CONTROL
K082162 · Beckman Coulter, Inc. · Feb 2009
COULTER 6C CELL CONTROL, MODELS 628027 & A59925
K081822 · Beckman Coulter, Inc. · Jan 2009